Dr. Ritin Bomb, MD

Dr. Bomb practices at Baptist Memorial Hospital-Memphis in Memphis, Tennessee, part of Baptist Memorial Health Care.

Dr. Bomb's NPI, 1720390578, was assigned on July 9, 2010. Dr. Bomb graduated from RNT Medical College in 1997. Dr. Bomb's Tennessee license number on file is 54823.

Dr. Bomb's primary practice is Baptist Memorial Hospital-Memphis, at 6019 Walnut Grove Road, Memphis, TN 38120 in Shelby County. The practice phone is (901) 226-5000.

Dr. Bomb's primary practice is Baptist Memorial Hospital-Memphis in Memphis, Tennessee, part of Baptist Memorial Health Care. Dr. Bomb is also affiliated with Methodist University Hospital. The medical group on file is Saint Francis Medical Partners. Dmand AI also links Dr. Bomb to 3 more hospitals, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bomb practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bomb's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bomb is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bomb's licenses on file in 6 states: Tennessee, Missouri, Mississippi, Minnesota, Louisiana and Texas.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and chronic skin ulcer among the conditions Dr. Bomb treats.

CMS data shows 5,743 Medicare services from Dr. Bomb across 25 procedure codes in 2024, for 460 Medicare patients. Medicare paid $361,598 for them.

CMS counts 460 Medicare patients who saw Dr. Bomb in 2024. The largest group is 65 to 74, with 202 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bomb's median patient age at 66, with 57% women.

In 2024, Dr. Bomb wrote 1,785 Medicare Part D claims for 363 patients. 83% of them were for generic drugs. CMS names the drug for 1,618 of them, across 32 drugs with 11 or more claims each, at $368,802 in total drug cost. In 2023, CMS named 920 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Bomb for performance year 2024, reported individually. Dr. Bomb accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Bomb, published from 2015 to 2018. Dr. Bomb's most frequent co-authors are Rami Nadim Khouzam, MD, Oluwaseun Ayodele Akinseye, MD and Anand Chockalingam, MD.

CMS Open Payments shows 694 general payments to Dr. Bomb from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. Medtronic Vascular, Inc. paid the most, $7,275.

Dr. Bomb graduated from RNT Medical College in 1997. Dr. Bomb is a member of ACC.

Dr. Bomb is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.